Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer

SAN DIEGO, May 16, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Laurie Stelzer as the Company’s Chief Financial Officer (CFO) effective May 16, 2022. Laurie will report to the Company’s Chief…

Click here to view original post